Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...
查看详情Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipe...
Guangzhou, China -- Bio-Thera Solutions, announced the initiation of a Phase III clinical trial evaluating the efficacy...
Bio-Thera Solutions, a global biopharmaceutical company today announced that the China National Drug Administration (CND...
